Convergent Thinking, Creative Application

At Jefferson, we work hard to bring people, ideas and resources together in new ways—creating opportunities to apply knowledge, methods and technologies from one field, to questions asked in another. This year, our research report offers a glimpse of how convergent thinking is manifest across our institution – through multidisciplinary teams who combine their research to solve challenges, as well as those who team up to tease apart the interwoven problems that comprise complex challenges.

Our research enterprise is robust and growing. We are having major impact across the research spectrum—from making fundamental discoveries on the nanoscale and atomic levels to the translation and application of new therapies, processes and products in health care, industry, local communities and multifaceted ecosystems.

Discover the many ways that Jefferson researchers are moving past boundaries to pursue opportunity and surmount our world’s most significant challenges.

Read More About Our Research Vision

Toward Smarter, Healthier Cities

The Institute for Smart and Healthy Cities was launched in 2020 to support multidisciplinary research, innovation and education on the transformation of urban environments into more efficient, healthier and livable cities.

At Jefferson, we believe there is a kind of energy created when once-distinct disciplines intersect: the light of the resulting discovery is extraordinary, as is the warmth of human benefit from applying that discovery.

Mark L. Tykocinski, MD, Provost, Executive Vice President for Academic Affairs, Thomas Jefferson University, The Anthony F. and Gertrude M. DePalma Dean, Sidney Kimmel Medical College

Sending Jefferson Research to Space

Three of Jefferson’s collaborative research projects will become part of the upcoming Rakia space mission, the first-ever private mission to the International Space Station.

Research Stats

1,112

active studies across Thomas Jefferson University and Jefferson Health

60%

increase in clinical trials over 5 years

$84M+

in NIH funding – an approximate 38% increase since 2016